Mai Anh Huynh, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 6 | 2023 | 1329 | 2.000 |
Why?
|
Tattooing | 1 | 2023 | 58 | 0.910 |
Why?
|
Bone Diseases | 1 | 2022 | 416 | 0.640 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 11126 | 0.560 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 3 | 2009 | 168 | 0.450 |
Why?
|
Cell Shape | 1 | 2011 | 375 | 0.350 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 2249 | 0.350 |
Why?
|
Palliative Care | 4 | 2022 | 3493 | 0.340 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2023 | 1624 | 0.300 |
Why?
|
Axons | 3 | 2009 | 1685 | 0.280 |
Why?
|
Neoplasms | 5 | 2022 | 21696 | 0.280 |
Why?
|
Nerve Tissue Proteins | 4 | 2011 | 4463 | 0.250 |
Why?
|
Cerebellum | 2 | 2011 | 1488 | 0.240 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6364 | 0.240 |
Why?
|
Cadherins | 1 | 2009 | 907 | 0.240 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.230 |
Why?
|
Rats, Long-Evans | 5 | 2011 | 387 | 0.230 |
Why?
|
Neurons | 3 | 2011 | 9340 | 0.210 |
Why?
|
Cell Movement | 2 | 2011 | 5218 | 0.200 |
Why?
|
Thoracic Neoplasms | 1 | 2023 | 268 | 0.200 |
Why?
|
Transcription Factors | 5 | 2014 | 12207 | 0.180 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2023 | 450 | 0.170 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2021 | 252 | 0.170 |
Why?
|
Workflow | 1 | 2023 | 847 | 0.160 |
Why?
|
Health Facilities | 1 | 2023 | 572 | 0.160 |
Why?
|
Androgen Antagonists | 2 | 2016 | 1377 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1180 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 3759 | 0.130 |
Why?
|
Telomere | 1 | 2021 | 910 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2021 | 1149 | 0.120 |
Why?
|
Radiotherapy Dosage | 2 | 2023 | 2879 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2014 | 2916 | 0.120 |
Why?
|
Immune System | 1 | 2019 | 806 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13104 | 0.110 |
Why?
|
Radiation Oncology | 1 | 2019 | 555 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2011 | 6366 | 0.110 |
Why?
|
Life Expectancy | 1 | 2019 | 1184 | 0.110 |
Why?
|
Transforming Growth Factor beta | 3 | 2014 | 2007 | 0.110 |
Why?
|
Spinal Neoplasms | 1 | 2019 | 760 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2013 | 408 | 0.100 |
Why?
|
Leucovorin | 1 | 2013 | 628 | 0.100 |
Why?
|
DNA Damage | 1 | 2021 | 2432 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5263 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12356 | 0.100 |
Why?
|
Smad2 Protein | 2 | 2008 | 156 | 0.100 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2023 | 77460 | 0.090 |
Why?
|
Camptothecin | 1 | 2013 | 576 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8642 | 0.090 |
Why?
|
Leupeptins | 1 | 2009 | 122 | 0.090 |
Why?
|
Pain | 2 | 2022 | 4988 | 0.080 |
Why?
|
Humans | 19 | 2023 | 744366 | 0.080 |
Why?
|
Animals, Newborn | 3 | 2009 | 2726 | 0.080 |
Why?
|
Propensity Score | 1 | 2015 | 1781 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2011 | 906 | 0.080 |
Why?
|
Fluorouracil | 1 | 2013 | 1619 | 0.080 |
Why?
|
Morphogenesis | 2 | 2009 | 751 | 0.080 |
Why?
|
Brachytherapy | 1 | 2015 | 1248 | 0.080 |
Why?
|
Rats | 5 | 2011 | 24252 | 0.080 |
Why?
|
Blotting, Western | 2 | 2014 | 5181 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3590 | 0.070 |
Why?
|
Prospective Studies | 3 | 2022 | 53290 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2530 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2009 | 2088 | 0.070 |
Why?
|
Male | 7 | 2022 | 350115 | 0.070 |
Why?
|
Growth Cones | 1 | 2006 | 117 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2011 | 19233 | 0.070 |
Why?
|
Purines | 1 | 2009 | 594 | 0.070 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2009 | 671 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2006 | 385 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1862 | 0.060 |
Why?
|
Transfection | 2 | 2009 | 5895 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9688 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5223 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 871 | 0.060 |
Why?
|
Cell Differentiation | 3 | 2011 | 11486 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 12802 | 0.050 |
Why?
|
Animals | 8 | 2019 | 168768 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
Exoribonucleases | 1 | 2021 | 95 | 0.050 |
Why?
|
RNA Helicases | 1 | 2021 | 142 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2014 | 3690 | 0.050 |
Why?
|
Protein Binding | 3 | 2021 | 9384 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2008 | 2418 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2021 | 894 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3799 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8861 | 0.040 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2850 | 0.040 |
Why?
|
Death | 1 | 2022 | 678 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 63107 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3464 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 976 | 0.040 |
Why?
|
RNA Interference | 3 | 2014 | 2890 | 0.040 |
Why?
|
CpG Islands | 1 | 2021 | 1170 | 0.040 |
Why?
|
Cerebellar Cortex | 2 | 2008 | 107 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 861 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5023 | 0.030 |
Why?
|
Signal Transduction | 2 | 2009 | 23404 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2649 | 0.030 |
Why?
|
Sumoylation | 1 | 2014 | 83 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 12073 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39052 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 393 | 0.030 |
Why?
|
Cell Cycle | 1 | 2021 | 2967 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2014 | 276 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2021 | 3505 | 0.030 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.020 |
Why?
|
Stents | 1 | 2023 | 3282 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2839 | 0.020 |
Why?
|
Aged | 3 | 2020 | 163288 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2009 | 148 | 0.020 |
Why?
|
Mink | 1 | 2008 | 44 | 0.020 |
Why?
|
E1A-Associated p300 Protein | 1 | 2009 | 131 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 72296 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 213390 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3531 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2009 | 261 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 40075 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 16000 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2700 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1678 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 767 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6111 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 937 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9240 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4208 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16690 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2006 | 1454 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13814 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7798 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2006 | 1549 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8662 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 1335 | 0.010 |
Why?
|
Brain | 1 | 2006 | 26388 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 3001 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2006 | 2969 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35425 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2006 | 3024 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7721 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13035 | 0.010 |
Why?
|
Adult | 2 | 2020 | 214052 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11525 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10483 | 0.010 |
Why?
|
Female | 2 | 2020 | 380193 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81201 | 0.000 |
Why?
|